(Q37052214)

17 August 2017

Severe QT interval prolongation associated with moxifloxacin: a case report (English)

1 reference

17 August 2017

1 reference

Tetsuro Koide

1

1 reference

17 August 2017

Masato Shiba

2

1 reference

17 August 2017

Katsuhiro Tanaka

3

1 reference

17 August 2017

Masatoshi Muramatsu

4

1 reference

17 August 2017

Satoshi Ishida

5

1 reference

17 August 2017

Yoshihiro Kondo

6

1 reference

17 August 2017

Keiko Watanabe

7

1 reference

17 August 2017

19 December 2008

1 reference

17 August 2017

1 reference

17 August 2017

1

1 reference

17 August 2017

1

1 reference

17 August 2017

409

1 reference

Creative Commons Attribution 2.0 Generic

17 August 2017

start time

1 December 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621134

Long QT syndrome caused by noncardiac drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621134

Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621134

The safety profile of the fluoroquinolones.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621134

A method for estimating the probability of adverse drug reactions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621134

International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621134

Famotidine and long QT syndrome

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621134

Moxifloxacin and torsade de pointes

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19099576

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19099576

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An evaluation of the impact of gender and age on QT dispersion in healthy subjects

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19099576

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1757-1626-1-409

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

PubMed publication ID

19099576

1 reference